Meanwhile, SI113, a small molecule SGK1 inhibitor, combined with quinacrine can synergistically inhibit GBM growth properties in ADF, U373MG, and T98G GBM cells, including neurospheres [149]. This evidence concerns the gene SGK1 and glioblastoma.